Hims & Hers Health, Inc.
Hims & Hers Health, Inc. Files Prospectus Supplement for Acquisition Shares
Summary
Hims & Hers Health, Inc. (Hims) has filed a prospectus supplement dated September 9, 2024, to register 976,341 shares of its Class A common stock issued to Nivagen Pharmaceuticals, Inc. in connection with Hims' acquisition of 100% of the membership interests of Seaview Enterprises LLC (d/b/a MedisourceRx) on September 5, 2024. The offering of these shares is exempt from registration under the Securities Act of 1933. A legal opinion regarding the shares is also filed as an exhibit.
Profitelligence Alerts
Get alerts for HIMS
Be first to know when Hims & Hers Health, Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. is a telehealth service provider that aims to simplify and enhance healthcare access for consumers. The company specializes in personal care and wellness products and services, offering both prescription and over-the-counter solutions. With a focus on destigmatizing health and wellness issues, Hims & Hers addresses areas such as dermatology, sexual health, hair care, and mental wellness, appealing to a broad demographic looking for convenient and private healthcare options. By facilitating online consultations with licensed medical professionals, the company allows users to receive medical advice, treatments, and prescriptions, all accessible from the comfort of their homes. Hims & Hers plays a significant role in the growing digital healthcare market, leveraging technology to provide more accessible and personalized healthcare experiences. Headquartered in San Francisco, the company capitalizes on the increase in demand for telehealth services, buoyed by advancements in digital health trends and the expanding e-commerce space for healthcare solutions.
Official SEC Documents
Advertisement